Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Background: Accurate prognostication following cardiac arrest (CA) is crucial for informing clinical decisions. Current guidelines do not recommend a specific time point for recording somatosensory evoked potentials (SSEPs) after CA. We evaluated the ability of ultra-early short- and middle-latency SSEPs to predict good an poor neurological outcome and compared its accuracy with that of other predictors recorded early after CA.

Methods: Prospective single-centre study. Sixty-five comatose adults underwent a multimodal prognostic assessment, including neurophysiological (SSEPs and electroencephalogram [EEG]), clinical (pupillary reflexes and myoclonus), and imaging indices (brain computed tomography [CT]) within 6h post-CA. Serum neuron-specific enolase (NSE) was sampled 12h post-CA. We analysed the SSEPs N20 wave amplitude and duration, and the presence of the middle-latency N70 wave. Poor outcome was defined as a Cerebral Performance Category (CPC) of 3-5 at hospital discharge.

Results: A bilaterally absent N20 wave predicted poor outcome with 100[89-100]% specificity and 67[48-82]% sensitivity. Adding low-amplitude (<1.2 µV), prolonged (>10 milliseconds) N20 waves without N70 increased sensitivity to 93[79-99]% without compromising specificity. Conversely, a high-amplitude (<3 µV) N20 wave with normal duration with preserved N70 predicted good outcome with 94[79-99]% sensitivity and 100[89-100]% specificity. SSEPs outperformed all other early prognostic indices for both good and poor outcome prediction. All poor outcome patients had at least two concordant unfavourable predictors.

Conclusions: Ultra-early quantitative assessment of short- and middle-latency SSEPs provides highly accurate prediction of both good and poor neurological outcomes after CA. This approach may enhance early clinical decision-making and warrants validation in larger cohorts.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.resuscitation.2025.110801DOI Listing

Publication Analysis

Top Keywords

poor outcome
12
ultra-early short-
8
short- middle-latency
8
predict good
8
good poor
8
cardiac arrest
8
n20 wave
8
middle-latency ssep
4
ssep accurately
4
accurately predict
4

Similar Publications

Unlabelled: Leptomeningeal metastasis (LM) is a severe complication of solid malignancies, including lung adenocarcinoma, characterized by poor prognosis and diagnostic challenges. This study assesses whether curvilinear peri-brainstem hyperintense signals on MRI are a characteristic feature of LM in lung adenocarcinoma patients.

Methods: This retrospective study analyzed data from multiple centers, encompassing lung adenocarcinoma patients with peri-brainstem curvilinear hyperintense signals on MRI between January 2016 and March 2022.

View Article and Find Full Text PDF

PRMT1-Mediated PARP1 Methylation Drives Lung Metastasis and Chemoresistance via P65 Activation in Triple-Negative Breast Cancer.

Research (Wash D C)

September 2025

State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou 510060, China.

Triple-negative breast cancer (TNBC) is the most aggressive breast cancer subtype, characterized by a high propensity for metastasis, poor prognosis, and limited treatment options. Research has demonstrated a substantial correlation between the expression of protein arginine N-methyltransferase 1 (PRMT1) and enhanced proliferation, metastasis, and poor outcomes in TNBC. However, the specific role of PRMT1 in lung metastasis and chemoresistance remains unclear.

View Article and Find Full Text PDF

Background: Vulvovaginal Candidiasis (VVC) is a condition commonly caused by . It is the second most common infection of the female genitalia affecting many women worldwide. Studies have identified unhealthy genital care practices to be associated with the infection among women including expectant mothers.

View Article and Find Full Text PDF

Nutritional status, immunonutrition, and gut microbiome: a coming of age for immunotherapy?

Front Immunol

September 2025

Clinical Nutrition and Dietetics Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.

In the last decades, immunotherapy has revolutionized cancer treatment. Despite its success, a significant number of patients fail to respond, and the underlying causes of ineffectiveness remain poorly understood. Factors such as nutritional status and body composition are emerging as key predictors of immunotherapy outcomes.

View Article and Find Full Text PDF

Unraveling epigenetic drivers of immune evasion in gliomas: mechanisms and therapeutic implications.

Front Immunol

September 2025

Precision Pharmacy and Drug Development Center, Department of Pharmacy, Tangdu Hospital, Fourth Military Medical University, Xi'an, Shaanxi, China.

Gliomas are the most common primary malignant tumors of the central nervous system (CNS), and despite progress in molecular diagnostics and targeted therapies, their prognosis remains poor. In recent years, immunotherapy has emerged as a promising treatment modality in cancer therapy. However, the inevitable immune evasion by tumor cells is a key barrier affecting therapeutic efficacy.

View Article and Find Full Text PDF